Genomics

DNA sequence

Genomics is the study of the body’s genes, their functions and their influence on the growth, development and working of the body – using a variety of techniques to look at the body’s DNA and associated compounds.

The UK is recognised worldwide as a leader in genomics and the unique structure of the NHS is allowing us to deliver these advances at scale and pace for patient benefit.

The role of NHS England and NHS Improvement is to enable the NHS to harness the power of genomic medicine and science to improve the health of our population as part of our commitments in the NHS Long Term Plan. We are doing this through the NHS Genomic Medicine Service.

The NHS is a world-leading healthcare system in its use of cutting-edge genomic technologies. We deliver faster and more accurate diagnoses for inherited and acquired disease, personalise treatments and interventions so they are more effective and predict and prevent certain conditions before they develop.

100,000 Genomes Project

The world-leading initiative to sequence 100,000 genomes from people with cancer and families with rare disease.

Personalised medicine

Providing better management of people’s health by moving away from a ‘one size fits all’ approach.

You may also be interested in

What is genomics?

Watch this short video from Health Education England’s Genomics Education Programme, which outlines what genomics is, and the ways it can improve patient care.

It also explores how genomics can track and treat infections like MRSA and tuberculosis (TB), improving and saving lives.

What does genomics mean for patients?

Jessica is one of the first children to receive a diagnosis from the 100,000 Genomes Project.

In this video from Genomics England, Jessica’s family talk about what it means to them, and how it will affect her treatment.

News and blogs

NHS gives cancer patients genetic test to select best treatment

Patients with the cancers will be offered the rapid new test to help decide whether to go ahead with treatment, opt for a lower dose or use a different method of tackling tumours. While most patients undergoing chemotherapy do not suffer sever side effects a small number taking certain drugs called fluoropyrimidines (5-FU and capecitabine) […]

See all genomics blog posts

See all genomics news